TTK Healthcare
TTKHLTCARE NSE
TTK Healthcare
DiversifiedNSE: TTKHLTCARE BSE: 507747
Key Fundamentals
MicrocapDiversified GroupDiversifiedMarket Cap
₹1,594 Cr
Volatility
Moderate
P/E Ratio
21.31
EBITDA
₹98.30 Cr
Return on Equity
5.89%
Debt to Equity
0.02
Book Value
₹785.85
EPS
₹44.94
52W High
₹1,247
52W Low
₹735
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 20.4%
Weaknesses
3- Company has a low return on equity of 6.54% over last 3 years.
- Earnings include an other income of Rs.66.9 Cr.
- Working capital days have increased from 86.1 days to 161 days
Growth Rate
Revenue Growth
6.5% higher than
3Y
Net Income Growth
-19.58% higher than
3Y
Cash Flow Change
-431% lower than
3Y
ROE
-23.21% lower than
3Y
ROCE
-26.94% lower than
3Y
EBITDA Margin (Avg.)
-12.99% higher than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 186 | 184 | 181 | 208 | 198 | 205 | 190 | 226 | 204 | 209 | 218 | 258 |
| Expenses | 192 | 176 | 179 | 169 | 201 | 190 | 197 | 178 | 224 | 198 | 202 | 207 | 243 |
| Operating Profit | 10 | 10 | 5 | 12 | 7 | 8 | 8 | 12 | 3 | 5 | 7 | 11 | 15 |
| OPM % | 5% | 5% | 2.9% | 7% | 3.3% | 4.2% | 3.8% | 6% | 1.2% | 2.6% | 3.4% | 5% | 6% |
| Other Income | 15 | 16 | 16 | 16 | 37 | 18 | 18 | 13 | 18 | 19 | 10 | 21 | 17 |
| Interest | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| PBT | 21 | 22 | 18 | 24 | 41 | 23 | 23 | 22 | 18 | 21 | 14 | 30 | 29 |
| Tax % | 24% | 26% | 27% | 25% | 23% | 26% | 26% | 26% | 26% | 4% | 25% | 26% | 26% |
| Net Profit | 16 | 16 | 13 | 18 | 32 | 17 | 17 | 16 | 13 | 20 | 11 | 22 | 21 |
| EPS in Rs | 11.09 | 11.33 | 9.12 | 12.93 | 22.35 | 12.17 | 11.84 | 11.43 | 9.2 | 14.43 | 7.45 | 15.4 | 15.06 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 483 | 519 | 528 | 578 | 628 | 646 | 476 | 599 | 725 | 753 | 801 | 857 | 888 |
| Expenses | 453 | 478 | 489 | 535 | 578 | 617 | 457 | 577 | 694 | 715 | 767 | 831 | 850 |
| Operating Profit | 30 | 40 | 38 | 43 | 50 | 28 | 19 | 22 | 31 | 37 | 35 | 26 | 38 |
| OPM % | 6% | 8% | 7% | 7% | 8% | 4.4% | 4.1% | 3.6% | 4.3% | 5% | 4.3% | 3% | 4.3% |
| Other Income | 7 | 6 | 6 | 8 | 8 | 9 | 28 | 42 | 643 | 63 | 85 | 68 | 67 |
| Interest | 4 | 3 | 3 | 5 | 3 | 3 | 2 | 3 | 5 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 7 | 12 | 15 | 15 | 14 | 13 | 13 | 13 | 13 | 8 | 9 | 9 |
| PBT | 26 | 36 | 29 | 30 | 39 | 19 | 32 | 48 | 657 | 84 | 108 | 83 | 94 |
| Tax % | 39% | 36% | 36% | 40% | 38% | 37% | -44% | 13% | 3% | 25% | 25% | 20% | — |
| Net Profit | 16 | 23 | 19 | 18 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | 74 |
| EPS in Rs | 20.81 | 29.19 | 24.13 | 12.86 | 17.25 | 8.72 | 32.87 | 29.43 | 453 | 44.47 | 57.79 | 46.48 | 52.34 |
| Div. Payout % | 22% | 17% | 21% | 39% | 29% | 34% | 18% | 34% | 2% | 22% | 17% | 22% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 110 | 128 | 150 | 219 | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| Borrowings | 42 | 38 | 23 | 47 | 29 | 30 | 19 | 22 | 27 | 23 | 24 | 24 |
| Other Liabilities | 115 | 128 | 104 | 127 | 136 | 152 | 180 | 207 | 189 | 183 | 192 | 190 |
| Total Liabilities | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
| Fixed Assets | 52 | 106 | 99 | 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 |
| CWIP | 46 | 1 | 0 | 1 | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | 0 | 10 | 9 | 9 | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| Other Assets | 177 | 185 | 177 | 288 | 304 | 325 | 395 | 463 | 1,083 | 1,118 | 1,189 | 1,246 |
| Total Assets | 275 | 303 | 285 | 407 | 416 | 431 | 494 | 559 | 1,170 | 1,206 | 1,281 | 1,329 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 39 | 37 | 18 | 25 | 17 | 20 | 96 | 45 | -25 | -5 | -4 | -21 |
| Investing | -49 | -27 | 5 | -22 | 10 | -13 | -77 | -30 | 32 | 28 | 20 | 52 |
| Financing | 3 | -11 | -23 | -7 | -31 | -10 | -17 | -10 | -12 | -22 | -18 | -18 |
| Net Cash Flow | -7 | 0 | 0 | -4 | -4 | -4 | 2 | 5 | -6 | 2 | -2 | 13 |
| Free Cash Flow | -10 | 21 | 12 | 21 | 13 | 8 | 95 | 42 | -36 | -15 | 6 | -25 |
| CFO/OP | 176 | 122 | 67 | 84 | 62 | 108 | 391 | 248 | -28 | 54 | 68 | -31 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 33 | 24 | 35 | 47 | 43 | 46 | 33 | 46 | 42 | 41 | 47 |
| Inventory Days | 62 | 66 | 65 | 80 | 77 | 101 | 123 | 102 | 89 | 105 | 107 | 98 |
| Days Payable | 50 | 53 | 100 | 130 | 101 | 121 | 170 | 134 | 116 | 110 | 106 | 83 |
| Cash Conversion Cycle | 46 | 46 | -11 | -16 | 22 | 23 | -2 | 1 | 19 | 36 | 43 | 63 |
| Working Capital Days | -31 | -38 | -24 | -30 | -6 | -3 | -32 | -28 | 4 | 49 | 48 | 161 |
| ROCE % | 20% | 23% | 18% | 15% | 15% | 8% | 6% | 8% | 10% | 9% | 9% | 8% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view TTK Healthcare insights
31 extracted metrics + investor summaries across FY08–FY26.
Documents
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026. 2 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026.
5
Announcement under Regulation 30 (LODR)-Change in Management
2 Feb - Mr. N Ramesh Rajan completed second and final term; ceased as Independent Director effective Feb 03, 2026. 2 Feb - Mr. N Ramesh Rajan completed second and final term; ceased as Independent Director effective Feb 03, 2026.
Frequently Asked Questions about TTK Healthcare
What does TTK Healthcare Ltd do?
TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. Human
Pharma was divested in May 2022;
agreements to sell EVA and Good
Home were signed in July 2026.[1][2]
Where is TTK Healthcare Ltd (TTKHLTCARE) listed?
TTK Healthcare Ltd trades as TTKHLTCARE on the NSE and under code 507747 on the BSE.
Which sector does TTK Healthcare Ltd belong to?
TTK Healthcare Ltd is classified under the Diversified sector.
What is the market capitalisation of TTK Healthcare Ltd?
TTK Healthcare Ltd has a market capitalisation of ₹1,594 Cr, which places it in the Small Cap band.
What is the PE ratio of TTK Healthcare Ltd?
TTK Healthcare Ltd trades at a PE ratio of 21.31, on earnings per share of ₹44.94, against a book value of ₹785.85 per share.
What is the 52-week high and low of TTK Healthcare Ltd?
Over the last 52 weeks TTK Healthcare Ltd has traded between ₹735 and ₹1,247.
Does TTK Healthcare Ltd pay dividends?
TTK Healthcare Ltd has a dividend yield of 0.88%.
What is the Return on Equity (ROE) of TTK Healthcare Ltd?
TTK Healthcare Ltd reported a return on equity of 5.89%. Its debt-to-equity ratio is 0.02.
Company Information
TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. Human Pharma was divested in May 2022; agreements to sell EVA and Good Home were signed in July 2026.[1][2]
Website ttkhealthcare.com
CEO Mr. T. T. Raghunathan B.Com.
Employees 1,339
Listed 2015-12-02
Face Value ₹ 10
Issued Size 1,41,30,333
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TTKHLTCARE.md for TTK Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.